\begin{rubric}{Appointments}
	\entry*[01/2022 - \textit{Present}]
		\textbf{Sr Computational Scientist}, Altos Labs
\entry*[07/2020 - \textit{Present}]
	\textbf{Visiting Scholar, Northwestern University}\par
	\textbf{Lab of Ilya Ruvinsky}
\entry*[03/2021 - 01/2022]
	\textbf{Senior Scientist I}, Rheos Medicines\par
	Rheos was unable to secure Series B funding in 2021 and closed its doors in 2022.
\entry*[11/2019 - 3/2021]
	\textbf{Computational Biologist II}, eGenesis\par
	I computationally designed compendium of pig promoters that stably
	express genes ubiquitously or with high tissue-specificy at desired levels with
	low burstiness, and developed technologies to identify safe harbors.
\entry*[01/2019--11/2019]
		\textbf{Postdoctoral Associate, MIT},\par
		\textbf{Lab of Eric J. Alm}
\end{rubric}
